Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH (NASH)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01672879
First received: August 22, 2012
Last updated: September 15, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2024
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)